A milder form of NSRP1-associated neurodevelopmental disorder, caused by a missense variant in the nuclear localization signal.

NSRP1 intellectual disability neurodevelopmental delay whole‐genome sequencing

Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
29 May 2024
Historique:
revised: 11 04 2024
received: 04 03 2024
accepted: 14 05 2024
medline: 29 5 2024
pubmed: 29 5 2024
entrez: 29 5 2024
Statut: aheadofprint

Résumé

Nuclear Speckle Splicing Regulator Protein 1 (NSRP1) is a splice factor found in nuclear speckles, which are small membrane-free organelles implicated in epigenetic regulation, chromatin organization, DNA repair, and RNA modification. Bi-allelic loss-of-function variants in NSRP1 have recently been identified in patients suffering from a severe neurodevelopmental disorder, presenting with neurodevelopmental delay, epilepsy, microcephaly, hypotonia, and spastic cerebral palsy. Described patients acquired neither independent walking nor speech and often showed anomalies on cerebral MRI. Here we describe the case of a 14-year-old girl with motor and language delay as well as intellectual disability, who presents an ataxic gait but walks without assistance and speaks in short sentences. Whole-genome sequencing revealed the compound heterozygous NSRP1 variants c.114 + 2T > G and c.1595T > A (p.Val532Glu). Functional validation using HEK293T cells transfected with either wild-type or mutated GFP-tagged Nsrp1 suggests that the Val532Glu variant interferes with the function of the nuclear localization signal, and leads to mislocalization of NSRP1 in the cytosol, thus confirming the pathogenicity of the observed variant. This case helps to expand the phenotypic and genetic spectrum associated with pathogenic NSRP1 variants and indicates that this diagnosis should also be suspected in patients with milder phenotypes.

Identifiants

pubmed: 38808951
doi: 10.1002/ajmg.a.63727
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

e63727

Subventions

Organisme : Belgian Kids'
Organisme : Brussels - Capital Region - Innoviris

Informations de copyright

© 2024 Wiley Periodicals LLC.

Références

Calame, D. G., Bakhtiari, S., Logan, R., Coban‐Akdemir, Z., Du, H., Mitani, T., Fatih, J. M., Hunter, J. V., Herman, I., Pehlivan, D., & Jhangiani, S. N. (2021). Biallelic loss‐of‐function variants in the splicing regulator NSRP1 cause a severe neurodevelopmental disorder with spastic cerebral palsy and epilepsy. Genetics in Medicine, 23(12), 2455–2460.
Galganski, L., Urbanek, M. O., & Krzyzosiak, W. J. (2017). Nuclear speckles: Molecular organization, biological function and role in disease. Nucleic Acids Research, 45(18), 10350–10368.
Gall, J. G., Bellini, M., Wu, Z., & Murphy, C. (1999). Assembly of the nuclear transcription and processing machinery: Cajal bodies (coiled bodies) and transcriptosomes. Molecular Biology of the Cell, 10(12), 4385–4402.
Kim, C. H., Kim, Y. D., Choi, E. K., Kim, H. R., Na, B. R., Im, S. H., & Jun, C. D. (2016). Nuclear speckle‐related protein 70 binds to serine/arginine‐rich splicing factors 1 and 2 via an arginine/serine‐like region and counteracts their alternative splicing activity. The Journal of Biological Chemistry, 291(12), 6169–6181.
Kim, C. H., Park, S. M., Lee, S. j., Kim, Y. D., Jang, S. H., Woo, S. M., Kwon, T. K., Park, Z. Y., Chung, I. J., Kim, H. R., & Jun, C. D. (2021). NSrp70 is a lymphocyte‐essential splicing factor that controls thymocyte development. Nucleic Acids Research, 49(10), 5760–5778.
Kim, Y. D., Lee, J. Y., Oh, K. M., Araki, M., Araki, K., Yamamura, K., & Jun, C. D. (2011). NSrp70 is a novel nuclear speckle‐related protein that modulates alternative pre‐mRNA splicing in vivo. Nucleic Acids Research, 39(10), 4300–4314.
Kovacevic, I., Ho, R., & Cram, E. J. (2012). CCDC‐55 is required for larval development and distal tip cell migration in C. elegans. Mechanisms of Development, 128(11–12), 548–559.
Lee, S. H., Kim, C., Lee, H. K., Kim, Y. K., Ismail, T., Jeong, Y., Park, K., Park, M. J., Park, D. S., & Lee, H. S. (2016). NSrp70 is significant for embryonic growth and development, being a crucial factor for gastrulation and mesoderm induction. Biochemical and Biophysical Research Communications, 479(2), 238–2344.
Morimoto, M., & Boerkoel, C. F. (2013). The role of nuclear bodies in gene expression and disease. Biology, 2(3), 976–1033.
Regan‐Fendt, K. E., & Izumi, K. (2023). Nuclear speckleopathies: Developmental disorders caused by variants in genes encoding nuclear speckle proteins. Human Genetics, 143, 529–544.
Saitoh, N., Spahr, C. S., Patterson, S. D., Bubulya, P., Neuwald, A. F., & Spector, D. L. (2004). Proteomic analysis of interchromatin granule clusters. Molecular Biology of the Cell, 15(8), 3876–3890.
Ségalat, L., & Lepesant, J. A. (1992). Spatial distribution of the Sm antigen in drosophila early embryos. Biology of the Cell, 75(3), 181–185.
Spector, D. L., & Lamond, A. I. (2011). Nuclear speckles. Cold Spring Harbor Perspectives in Biology, 3(2), a000646.

Auteurs

Sebastian Neuens (S)

Department of Genetics, Hôpital Universitaire Des Enfants Reine Fabiola, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.

Maiza Kausar (M)

School of Life Sciences, Immune Synapse and Cell Therapy Research Center, Gwangju Institute of Science and Technology (GIST), Gwangju, South Korea.

Sun-Kyoung Kang (SK)

School of Life Sciences, Immune Synapse and Cell Therapy Research Center, Gwangju Institute of Science and Technology (GIST), Gwangju, South Korea.

Julie Soblet (J)

Department of Genetics, Hôpital Universitaire Des Enfants Reine Fabiola, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Center for Human Genetics, Hôpital Erasme, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Interuniversity Institute of Bioinformatics in Brussels (IB)2, Université Libre de Bruxelles-Vrije Universiteit Brussel, Brussels, Belgium.

Sonia Van Dooren (S)

Interuniversity Institute of Bioinformatics in Brussels (IB)2, Université Libre de Bruxelles-Vrije Universiteit Brussel, Brussels, Belgium.
Interuniversity Genomics High Throughput Core (BRIGHTcore), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
Vrije Universiteit Brussel (VUB), Clinical Sciences, Research Group Genetics, Reproduction and Development (GRAD), Centre for Medical Genetics, Universitair Ziekenhuis Brussel (UZ Brussel), Jette, Belgium.

Catharina Olsen (C)

Interuniversity Institute of Bioinformatics in Brussels (IB)2, Université Libre de Bruxelles-Vrije Universiteit Brussel, Brussels, Belgium.
Interuniversity Genomics High Throughput Core (BRIGHTcore), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
Vrije Universiteit Brussel (VUB), Clinical Sciences, Research Group Genetics, Reproduction and Development (GRAD), Centre for Medical Genetics, Universitair Ziekenhuis Brussel (UZ Brussel), Jette, Belgium.

Toon Janssen (T)

Interuniversity Genomics High Throughput Core (BRIGHTcore), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
Vrije Universiteit Brussel (VUB), Clinical Sciences, Research Group Genetics, Reproduction and Development (GRAD), Centre for Medical Genetics, Universitair Ziekenhuis Brussel (UZ Brussel), Jette, Belgium.

Ben Caljon (B)

Interuniversity Genomics High Throughput Core (BRIGHTcore), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
Vrije Universiteit Brussel (VUB), Clinical Sciences, Research Group Genetics, Reproduction and Development (GRAD), Centre for Medical Genetics, Universitair Ziekenhuis Brussel (UZ Brussel), Jette, Belgium.

Chang-Duk Jun (CD)

School of Life Sciences, Immune Synapse and Cell Therapy Research Center, Gwangju Institute of Science and Technology (GIST), Gwangju, South Korea.

Guillaume Smits (G)

Department of Genetics, Hôpital Universitaire Des Enfants Reine Fabiola, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Center for Human Genetics, Hôpital Erasme, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Interuniversity Institute of Bioinformatics in Brussels (IB)2, Université Libre de Bruxelles-Vrije Universiteit Brussel, Brussels, Belgium.

Sandra Coppens (S)

Center for Human Genetics, Hôpital Erasme, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.

Catheline Vilain (C)

Department of Genetics, Hôpital Universitaire Des Enfants Reine Fabiola, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Center for Human Genetics, Hôpital Erasme, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Interuniversity Institute of Bioinformatics in Brussels (IB)2, Université Libre de Bruxelles-Vrije Universiteit Brussel, Brussels, Belgium.

Classifications MeSH